Antibodies News and Research

RSS

Research shows new Zika virus vaccine that offers 100% protection in mice

Research presented by Farshad Guirakhoo, Ph.D., Chief Scientific Officer, GeoVax, Inc., at the ASM Microbe 2017 meeting showed a new Zika virus vaccine that gives 100% protection in mice.

5 Jun 2017

TSRI study reveals first-ever structure of Lassa virus protein

Before Ebola virus ever struck West Africa, locals were already on the lookout for a deadly pathogen: Lassa virus. With thousands dying from Lassa every year-;and the potential for the virus to cause even larger outbreaks- researchers are committed to designing a vaccine to stop it.

1 Jun 2017

Researchers find new way to block type 1 diabetes

Researchers at The Jackson Laboratory, Cyteir Therapeutics and collaborating institutions have found a way to protect beta cells from destruction -- achieving a longtime, elusive goal that could lead to therapies preventing type 1 diabetes (T1D).

1 Jun 2017

Therapeutic small molecules safely prevent blood clots without excessive bleeding

It may be possible to disrupt harmful blood clots in people at risk for heart attack or stroke without increasing their risk of bleeding, according to a new study published in Nature Communications.

31 May 2017

Novel vaccine therapy can generate immune responses in patients with HPV-related head and neck cancer

A novel vaccine therapy can generate immune responses in patients with head and neck squamous cell carcinoma (HNSCCa), according to researchers at the Abramson Cancer Center of the University of Pennsylvania.

31 May 2017

Cancer treatment may be effective therapy for psoriasis

HDAC inhibitors, already widely used to treat cancer, may be an effective therapy for psoriasis as well, scientists report.

31 May 2017

Clinical trial uses small molecule to treat men with incurable prostate cancer

NewYork-Presbyterian and Weill Cornell Medicine have begun the first clinical trial in the United States that uses a small molecule to treat men with progressive prostate cancer that has spread beyond the prostate and is no longer responding to hormonal therapy.

31 May 2017

New study documents prevalence of food allergies

Anecdotal evidence of food allergies abounds, but just how common are these allergies and intolerances? In a new study, investigators from Brigham and Women's Hospital combed through medical records from more than 2.7 million patients, identifying more than 97,000 with one or more documented food allergy or intolerance.

31 May 2017

Scientists could be one step closer to developing vaccines against viruses

Scientists could be one step closer to developing vaccines against viruses such as Zika, West Nile or HIV, according to Penn State College of Medicine researchers.

31 May 2017

Real-time imaging of influenza infection in mice can be promising evaluation tool

Real-time imaging of influenza infection in mice is a promising new method to quickly monitor disease progression and to evaluate whether candidate vaccines and treatments are effective in this animal model, according to National Institutes of Health scientists.

31 May 2017

Rice University scientists develop and evaluate analogs of potent cancer fighters

Rice University scientists have developed and evaluated analogs of potent anti-tumor agents known as epothilones using designs and methods that both improve their biological properties and simplify their manufacture.

31 May 2017

Scripps scientists make important advance in HIV vaccine design

Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design. The development was possible thanks to previous studies at TSRI showing the structures of a protein on HIV’s surface, called the envelope glycoprotein. The scientists used these structures to design a mimic of the viral protein from a different HIV subtype, subtype C, which is responsible for the majority of infections worldwide.

29 May 2017

Researchers can attack cancer by working together, says UNC Charlotte professor

MUC1 is a protein present on the cells that line most organs. It lubricates and protects them. When cells become malignant, the MUC1 protein changes and signals tumor cells to multiply.

27 May 2017

Immunotherapy can be more effective in NSCLC patients who received radiation therapy, study shows

A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.

25 May 2017

Researchers develop new method for rapidly sorting HIV viruses

Researchers at EMBL, ESPCI Paris, and the International AIDS Vaccine Initiative have developed a new technique for rapidly sorting HIV viruses, which could lead to more rapid development of a vaccine for HIV, as they report in Cell Chemical Biology.

25 May 2017

Study unravels mystery of how nerve cells are damaged in neurodegenerative diseases

A new study has uncovered a molecular mechanism in the prion protein, a protein responsible for neurodegenerative diseases, which may explain why nerve cells degenerate in these disorders.

25 May 2017

Cluster headaches: searching for effective therapies

Cluster headaches are probably the most painful types of pain a human can suffer and it is for no small reason that this condition is also sometimes referred to as suicide headache.

25 May 2017

FAU researchers use robot technology to gain insights into development of malignant melanoma

Malignant melanoma is one of the most common and dangerous types of cancer. Researchers at Friedrich-Alexander Universität Erlangen-Nürnberg investigated how and why brown pigmented moles turn into malignant melanoma using innovative robot technology.

23 May 2017

Researchers link intestinal fungi to increased risk of death in patients with alcoholic liver disease

Liver cirrhosis is the 12th leading cause of mortality worldwide and approximately half of those deaths are due to alcohol abuse.

23 May 2017

UT Southwestern research shows potential of new DNA vaccine in preventing Alzheimer’s disease

A new DNA vaccine when delivered to the skin prompts an immune response that produces antibodies to protect against toxic proteins associated with Alzheimer's disease – without triggering severe brain swelling that earlier antibody treatments caused in some patients.

23 May 2017

Antibodies News and Research

Research shows new Zika virus vaccine that offers 100% protection in mice

TSRI study reveals first-ever structure of Lassa virus protein

Researchers find new way to block type 1 diabetes

Therapeutic small molecules safely prevent blood clots without excessive bleeding

Novel vaccine therapy can generate immune responses in patients with HPV-related head and neck cancer

Cancer treatment may be effective therapy for psoriasis

Clinical trial uses small molecule to treat men with incurable prostate cancer

New study documents prevalence of food allergies

Scientists could be one step closer to developing vaccines against viruses

Real-time imaging of influenza infection in mice can be promising evaluation tool

Rice University scientists develop and evaluate analogs of potent cancer fighters

Scripps scientists make important advance in HIV vaccine design

Researchers can attack cancer by working together, says UNC Charlotte professor

Immunotherapy can be more effective in NSCLC patients who received radiation therapy, study shows

Researchers develop new method for rapidly sorting HIV viruses

Study unravels mystery of how nerve cells are damaged in neurodegenerative diseases

Cluster headaches: searching for effective therapies

FAU researchers use robot technology to gain insights into development of malignant melanoma

Researchers link intestinal fungi to increased risk of death in patients with alcoholic liver disease

UT Southwestern research shows potential of new DNA vaccine in preventing Alzheimer’s disease

Immunology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News